covid_cell_1_20’s weekly COVID-19 news round-up

pharmafile | May 26, 2021 | News story | Research and Development  

The past week has seen lots of positive COVID-19 news; a French study has found that dogs can detect COVID-19 with 97% accuracy, the vaccines have been found to be highly effective against the Indian variant, and the Moderna vaccine has shown 100% efficacy in teens.

 1. Dogs can detect COVID-19 with 97% accuracy, study finds – Published – 21/05/21

A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which means they are more effective than lateral flow tests.

 2. World’s first COVID-19 vaccine booster study launches in UK – Published – 20/05/2021

The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, the Cov-Boost study, led by University Hospital Southampton NHS Foundation Trust.

 3. EU signs contract for 1.8bn more Pfizer vaccines – Published – 20/05/21

 The European Commission has signed a deal with Pfizer-BioNTech to purchase an additional 1.8 billion doses of its COVID-19 vaccine today.

 4. Vaccines highly effective against Indian variant, study shows – Published 24/05/21 –

 A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are highly effective against the B.1.617.2 (Indian) variant.

 5. Moderna vaccine shows 100% efficacy in teens – Published – 26/05/21

Moderna’s TeenCOVE study, involving 3,700 adolescents aged 12 to less than 18 years old, observed no cases of COVID-19 after two doses of the vaccine.

Related Content

No items found

Latest content